Another point to consider is MYD88 mutation, and lymphocytic flow‐cytometric markers can become positive in other lymphoproliferative disorders, like marginal zone lymphoma (MZL) or chronic lymphocytic leukemia (CLL).8, 9. Here, MYD88 is linked to marginal zone lymphoma.